Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2013, Article ID 703163, 5 pages
http://dx.doi.org/10.1155/2013/703163
Research Article

Mast Cells Positive to Tryptase and c-Kit Receptor Expressing Cells Correlates with Angiogenesis in Gastric Cancer Patients Surgically Treated

1Department of Medical and Surgery Science, Clinical Surgery Unit, University of Catanzaro “Magna Graecia” Medical School, Viale Europa, Germaneto, 88100 Catanzaro, Italy
2Health Science Department, Pathology Unit, University of Catanzaro “Magna Graecia” Medical School, 88100 Catanzaro, Italy
3Department of Medical and Surgery Science, Cardiovascular Disease Unit, University of Catanzaro “Magna Graecia” Medical School, 88100 Catanzaro, Italy
4Surgery Unit, National Cancer Research Centre, Giovanni Paolo II, 70100 Bari, Italy
5Department of Surgery, Surgical Oncology Unit, Ospedale Morgagni-Pierantoni, 47121 Forlì, Italy
6Interventional Radiology Unit with Integrated Section of Translational Medical Oncology, National Cancer Research Centre, “Giovanni Paolo II”, 70100 Bari, Italy

Received 22 August 2013; Revised 13 October 2013; Accepted 21 October 2013

Academic Editor: Chunping Jiang

Copyright © 2013 Michele Ammendola et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Ranieri, A. Labriola, G. Achille et al., “Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma,” International Journal of Oncology, vol. 21, no. 6, pp. 1317–1323, 2002. View at Google Scholar · View at Scopus
  2. G. Ranieri, M. Ammendola, R. Patruno et al., “Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients,” International Journal of Oncology, vol. 35, no. 1, pp. 115–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Weidner, J. P. Semple, W. R. Welch, and J. Folkman, “Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma,” The New England Journal of Medicine, vol. 324, no. 1, pp. 1–8, 1991. View at Google Scholar · View at Scopus
  4. J. P. Kankkunen, I. T. Harvima, and A. Naukkarinen, “Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions,” International Journal of Cancer, vol. 72, no. 3, pp. 385–338, 1997. View at Publisher · View at Google Scholar
  5. L. Soucek, E. R. Lawlor, D. Soto, K. Shchors, L. B. Swigart, and G. I. Evan, “Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors,” Nature Medicine, vol. 13, no. 10, pp. 1211–1218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Ribatti, G. Ranieri, B. Nico, V. Benagiano, and E. Crivellato, “Tryptase and chymase are angiogenic in vivo in the chorioallantoic membrane assay,” International Journal of Developmental Biology, vol. 55, no. 1, pp. 99–102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Mangia, A. Malfettone, R. Rossi et al., “Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation,” Histopathology, vol. 58, no. 7, pp. 1096–1106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Ranieri, G. Gadaleta-Caldarola, V. Goffredo et al., “Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development,” Current Medicinal Chemistry, vol. 19, no. 7, pp. 938–944, 2012. View at Google Scholar · View at Scopus
  9. G. Ranieri, L. Passantino, R. Patruno et al., “The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy,” Oncology Reports, vol. 10, no. 5, pp. 1189–1193, 2003. View at Google Scholar · View at Scopus
  10. L. M. Coussens, W.W. Raymond, G. Bergers et al., “Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis,” Genes Development, vol. 13, no. 11, pp. 1382–1397, 1999. View at Publisher · View at Google Scholar
  11. M. Gulubova and T. Vlaykova, “Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer,” Journal of Gastroenterology and Hepatology, vol. 24, no. 7, pp. 1265–1275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Yano, M. Kinuta, H. Tateishi et al., “Mast cell infiltration around gastric cancer cells correlates with tumour angiogenesis and metastasis,” Gastric Cancer, vol. 2, no. 1, pp. 26–32, 1999. View at Publisher · View at Google Scholar
  13. M. Ammendola, R. Sacco, G. Donato et al., “Mast cell positive to tryptase correlates with metastatic lymph nodes in gastrointestinal cancers patients surgically treated,” Oncology, vol. 85, no. 2, pp. 111–116, 2013. View at Publisher · View at Google Scholar
  14. D. Ribatti, D. Guidolin, A. Marzullo et al., “Mast cells and angiogenesis in gastric carcinoma,” International Journal of Experimental Pathology, vol. 91, no. 4, pp. 350–356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Washington, “7th edition of the AJCC cancer staging manual: stomach,” Annals of Surgical Oncology, vol. 17, no. 12, pp. 3077–3079, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Tamura, A. Takeno, and H. Miki, “Lymph node dissection in curative gastrectomy for advanced gastric cancer,” International Journal of Surgical Oncology, vol. 2011, Article ID 748745, 8 pages, 2011. View at Publisher · View at Google Scholar
  17. G. Ranieri, L. Grammatica, R. Patruno et al., “A possible role of thymidine phosphorylase expression and5-fluorouracil increased sensitivity in oropharyngeal cancer patients,” Journal of Cellular and Molecular Medicine, vol. 11, no. 2, pp. 362–368, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Zhang, X. Wu, M. Zhang et al., “Small molecule R1498 as a well-tolerated and orally active kinase inhibitor for hepatocellular carcinoma and gastric cancer treatment via targeting angiogenesis and mitosis pathways,” PLoS One, vol. 8, no. 6, Article ID e65264, 2013. View at Google Scholar
  19. Y. Geng, X. Chen, J. Qiu et al., “Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer,” International Journal of Clinical Oncology, 2013. View at Publisher · View at Google Scholar
  20. X. Wang, X. Chen, J. Fang, and C. Yang, “Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth,” International Journal of Clinical and Experimental Pathology, vol. 6, no. 4, pp. 586–597, 2013. View at Google Scholar
  21. Y. Zhao, K. Wu, K. Cai et al., “Increased numbers of gastric-infiltrating mast cells and regulatory T cells are associated with tumor stage in gastric adenocarcinoma patients,” Oncology Letters, vol. 4, no. 4, pp. 755–758, 2012. View at Google Scholar
  22. S. Mukherjee, G. Bandyopadhyay, C. Dutta, A. Bhattacharya, R. Karmakar, and G. Barui, “Evaluation of endoscopic biopsy in gastric lesions with a special reference to the significance of mast cell density,” Indian Journal of Pathology and Microbiology, vol. 52, no. 1, pp. 20–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Ammendola, V. Zuccalà, R. Patruno et al., “Tryptase-positive mast cells and angiogenesis in keloids: a new post-surgical target for prevention,” Updates in Surgery, vol. 65, no. 1, pp. 53–57, 2013. View at Google Scholar
  24. B. Nico, D. Mangieri, E. Crivellato, A. Vacca, and D. Ribatti, “Mast cells contribute to vasculogenic mimicry in multiple myeloma,” Stem Cells and Development, vol. 17, no. 1, pp. 19–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Hallgren, S. Estrada, U. Karlson, K. Alving, and G. Pejler, “Heparin antagonists are potent inhibitors of mast cell tryptase,” Biochemistry, vol. 40, no. 24, pp. 7342–7349, 2001. View at Google Scholar · View at Scopus
  26. I. Fajardo and G. Pejler, “Human mast cell β-tryptase is a gelatinase,” Journal of Immunology, vol. 171, no. 3, pp. 1493–1499, 2003. View at Google Scholar · View at Scopus
  27. Y. Liu and B. M. Mueller, “Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways,” Biochemical and Biophysical Research Communications, vol. 344, no. 4, pp. 1263–1270, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Erba, L. Fiorucci, S. Pascarella, E. Menegatti, P. Ascenzi, and F. Ascoli, “Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug,” Biochemical Pharmacology, vol. 61, no. 3, pp. 271–276, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Mori, Y. Itoh, R. Shinohata, T. Sendo, R. Oishi, and M. Nishibiro, “Nafamostat mesilate is an extremely potent inhibitor of human tryptase,” Journal of Pharmacological Sciences, vol. 92, no. 4, pp. 420–423, 2003. View at Google Scholar · View at Scopus